Clinical Trials Browser

INDUSTRY × enzastaurin × Thoracic × Clear all

NCT00308750 2021-05-13

First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

218 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung

NCT00533429 2021-05-13

Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy

Phase 2 Completed

40 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung

NCT00415363 2020-11-05

Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy

Phase 2 Completed

109 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT00414960 2020-09-21

A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former Smokers

Phase 2 Completed

40 enrolled 12 charts

Lung Neoplasms

NCT00530621 2020-07-01

Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung Cancer

Phase 2 Completed

160 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung

NCT00105092 2007-05-01

Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung